Applied Genetic Technologies Corporation
AGTC
AGTC was delisted on the 30th of November, 2022.
55 hedge funds and large institutions have $22.4M invested in Applied Genetic Technologies Corporation in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 19 reducing their positions, and 18 closing their positions.
12% more call options, than puts
Call options by funds: $222K | Put options by funds: $199K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
14% less funds holding
Funds holding: 64 → 55 (-9)
37% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 19
42% less capital invested
Capital invested by funds: $38.9M → $22.4M (-$16.4M)
50% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$758K |
| 2 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$233K |
| 3 |
BlackRock
New York
|
+$160K |
| 4 |
Renaissance Technologies
New York
|
+$93.4K |
| 5 |
Two Sigma Investments
New York
|
+$91.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$1.76M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.05M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$510K |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$205K |
| 5 |
HF
HRT Financial
New York
|
-$172K |
AGTC Hedge Fund Activity: Q4 2021 in Review
55 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q4 2021, worth a combined $22.4M — down 42% from $38.9M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of AGTC and 9 opened new positions — a net loss of 9 holders — while 19 trimmed existing stakes and 12 added.
The largest buyer was Millennium Management, adding an estimated $758K. The largest seller was GSA Capital Partners, exiting entirely with an estimated $1.76M sold.
- 55 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q4 2021, down from 64 in Q3 2021.
- Funds reported $22.4M of Applied Genetic Technologies Corporation stock for Q4 2021, down 42% quarter-over-quarter.
- 9 funds opened new Applied Genetic Technologies Corporation positions in Q4 2021 and 18 closed out, a net change of -9 holders.
- The largest Applied Genetic Technologies Corporation buyer in Q4 2021 was Millennium Management, an estimated $758K added.
- The largest Applied Genetic Technologies Corporation seller in Q4 2021 was GSA Capital Partners, an estimated $1.76M sold.
Based on aggregated 13F filings for Q4 2021.